Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,352 | 492 | 36.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,908 | 26 | 27.9% |
| Consulting Fee | $7,508 | 3 | 26.5% |
| Travel and Lodging | $2,092 | 8 | 7.4% |
| Education | $484.94 | 34 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $10,775 | 36 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $4,627 | 55 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $3,035 | 10 | $0 (2024) |
| ABBVIE INC. | $2,827 | 117 | $0 (2024) |
| PFIZER INC. | $1,004 | 55 | $0 (2024) |
| Janssen Biotech, Inc. | $810.28 | 43 | $0 (2024) |
| LEO Pharma Inc. | $641.14 | 31 | $0 (2024) |
| GENZYME CORPORATION | $553.45 | 12 | $0 (2022) |
| Sun Pharmaceutical Industries Inc. | $525.08 | 31 | $0 (2023) |
| Promius Pharma LLC | $500.00 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,938 | 68 | Novartis Pharmaceuticals Corporation ($3,733) |
| 2023 | $4,333 | 60 | E.R. Squibb & Sons, L.L.C. ($2,940) |
| 2022 | $3,325 | 72 | Galderma Laboratories, L.P. ($2,045) |
| 2021 | $1,260 | 51 | GENZYME CORPORATION ($364.03) |
| 2020 | $1,174 | 63 | AbbVie Inc. ($376.56) |
| 2019 | $1,506 | 84 | AbbVie, Inc. ($307.10) |
| 2018 | $1,641 | 99 | Taro Pharmaceuticals USA, Inc. ($286.39) |
| 2017 | $10,166 | 66 | Galderma Laboratories, L.P. ($8,575) |
All Payment Transactions
563 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $15.10 | General |
| 12/17/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3.56 | General |
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.03 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $7.58 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Dermatology | ||||||
| 11/04/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.30 | General |
| 11/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $3,300.00 | General |
| 10/24/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $171.68 | General |
| 10/17/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: DERMATOLOGY | ||||||
| 10/16/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Dermatology | ||||||
| 09/27/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $12.22 | General |
| 09/25/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Dermatology | ||||||
| 09/23/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Dermatology | ||||||
| 09/17/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $98.76 | General |
| Category: DERMATOLOGY | ||||||
| 09/16/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: DERMATOLOGY | ||||||
| 09/10/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Dermatology | ||||||
| 09/03/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $21.00 | General |
| 08/28/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: Dermatology | ||||||
| 08/27/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/27/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.67 | General |
| 08/05/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Dermatology | ||||||
| 08/05/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $2.65 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 3,656 | 17,896 | $557,328 | $246,190 |
| 2022 | 18 | 3,715 | 23,223 | $601,339 | $268,976 |
| 2021 | 19 | 3,791 | 31,859 | $629,382 | $293,110 |
| 2020 | 19 | 3,767 | 32,649 | $630,395 | $270,212 |
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 582 | 691 | $95,358 | $41,645 | 43.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 661 | 782 | $78,591 | $33,395 | 42.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 337 | 383 | $74,972 | $32,511 | 43.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 430 | 430 | $72,885 | $30,382 | 41.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 342 | 367 | $58,353 | $26,615 | 45.6% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 46 | 11,800 | $29,500 | $15,129 | 51.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 221 | 221 | $24,365 | $11,922 | 48.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 505 | 2,283 | $22,830 | $11,408 | 50.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 89 | 91 | $15,789 | $7,140 | 45.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 68 | 68 | $17,221 | $6,987 | 40.6% |
| 96900 | Application of ultraviolet light to skin | Office | 2023 | 11 | 344 | $12,212 | $6,230 | 51.0% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 46 | 61 | $17,995 | $5,884 | 32.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 90 | 126 | $10,175 | $5,028 | 49.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 112 | 117 | $9,945 | $5,009 | 50.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 15 | 19 | $4,798 | $1,931 | 40.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 16 | 17 | $3,379 | $1,577 | 46.7% |
| 69100 | Biopsy of ear | Office | 2023 | 22 | 24 | $3,636 | $1,337 | 36.8% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 23 | 23 | $3,145 | $1,221 | 38.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 20 | 23 | $1,978 | $819.32 | 41.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 20 | 26 | $201.50 | $19.39 | 9.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 502 | 605 | $118,429 | $54,649 | 46.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 725 | 838 | $115,644 | $51,285 | 44.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 602 | 735 | $73,868 | $31,073 | 42.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 384 | 384 | $65,088 | $29,483 | 45.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 322 | 343 | $54,537 | $24,349 | 44.6% |
About Dr. William Dehart, DO
Dr. William Dehart, DO is a Dermatology healthcare provider based in Chesapeake, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1194936799.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Dehart, DO has received a total of $28,344 in payments from pharmaceutical and medical device companies, with $4,938 received in 2024. These payments were reported across 563 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($10,352).
As a Medicare-enrolled provider, Dehart has provided services to 14,929 Medicare beneficiaries, totaling 105,627 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Chesapeake, VA
- Active Since 05/24/2007
- Last Updated 06/24/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1194936799
Products in Payments
- ORACEA (Drug) $4,440
- MIRVASO (Drug) $4,107
- Sotyktu (Drug) $2,986
- EPSOLAY (Drug) $2,024
- EUCRISA (Drug) $1,004
- COSENTYX (Biological) $687.05
- RINVOQ (Biological) $562.33
- DUPIXENT (Biological) $553.17
- SKYRIZI (Biological) $507.38
- Promiseb Complete (Device) $500.00
- TREMFYA (Drug) $498.19
- Humira (Biological) $496.45
- Cimzia (Drug) $384.20
- ENSTILAR (Drug) $335.89
- ADBRY (Biological) $305.25
- HUMIRA (Biological) $287.64
- COSENTYX (Drug) $277.48
- TALTZ (Drug) $227.98
- Zoryve (Drug) $201.86
- AMELUZ (Drug) $192.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Chesapeake
Dr. Bruce Bauer, Md, MD
Dermatology — Payments: $16,091
Rachel Byrd, M.d, M.D
Dermatology — Payments: $9,501
Indira Sookdeo, Pa-C, PA-C
Dermatology — Payments: $8,990
Dr. Stephan Duran, Md, Ms, MD, MS
Dermatology — Payments: $3,378
Jerome Parsons, Md, MD
Dermatology — Payments: $877.57
Dr. John Burgess, M.d, M.D
Dermatology — Payments: $225.75